Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
08/10/2000 | WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy |
08/10/2000 | WO2000046240A2 Polypeptides involved in immune response |
08/10/2000 | WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
08/10/2000 | WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
08/10/2000 | WO2000046198A1 Anti-inflammatory indole derivatives |
08/10/2000 | WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists |
08/10/2000 | WO2000045828A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
08/10/2000 | WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor |
08/10/2000 | WO2000045814A1 Methods and compositions to enhance white blood cell count |
08/10/2000 | WO2000045804A2 Use of a polyanionic polysaccharide solution for the prevention of abscess formation |
08/10/2000 | WO2000045802A2 Use of (alpha)-d-glucans for promoting cutaneous wound and ulcer healing |
08/10/2000 | WO2000045786A1 Cholesterol sulfate compositions for enhancement of stratum corneum function |
08/10/2000 | WO2000045782A1 TESTOSTERONE-5α-REDUCTASE INHIBITORS, HAIR GROWTH STIMULANT/HAIR NOURISHMENT COMPOSITIONS AND COMPOSITIONS FOR WHITENING COSMETICS |
08/10/2000 | WO2000045774A1 Membrane lipid compositions |
08/10/2000 | WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production |
08/10/2000 | WO2000028975A3 Improved chemical process and pharmaceutical formulation |
08/10/2000 | WO2000027822A3 Tricyclic pyrazole derivatives |
08/10/2000 | WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives |
08/10/2000 | WO2000024911A3 Human phospholipases |
08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
08/10/2000 | DE19904801A1 Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis |
08/10/2000 | DE19904352C1 Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut Lipids containing soy extract, process for its preparation and to pharmaceutical or cosmetic composition and the use thereof for the prevention or treatment of dry skin |
08/10/2000 | DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses |
08/10/2000 | DE19903655A1 Hydrogel comprising protein or enzyme bonded to PEG via urea groups, useful as a dressing for wounds and burns |
08/10/2000 | CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
08/10/2000 | CA2362126A1 B7rp-1 polypeptides |
08/10/2000 | CA2361572A1 Prevention of abscess formation |
08/10/2000 | CA2361066A1 Inositol derivatives for inhibiting superoxide anion production |
08/10/2000 | CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor |
08/10/2000 | CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
08/10/2000 | CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
08/10/2000 | CA2357013A1 Anti-inflammatory indole derivatives |
08/10/2000 | CA2349703A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
08/10/2000 | CA2327512A1 Methods for promoting the healing of cutaneous wounds and ulcers using compositions of .alpha.-d-glucans |
08/09/2000 | EP1026150A1 (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same |
08/09/2000 | EP1025898A1 Nanoemulsion from alkoxylated alkenyl succinates or alkoxylated alkenyl succinates of glucose and its cosmetic, dermatologic, ophtalmologic and/or pharmaceutical uses |
08/09/2000 | EP1025860A2 Protein-containing hydrogels |
08/09/2000 | EP1025838A1 A cosmetic composition and a method for reducing the ageing processes of skin |
08/09/2000 | EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
08/09/2000 | EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
08/09/2000 | EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
08/09/2000 | EP1024792A1 Topical antifungal composition |
08/09/2000 | EP1024784A1 Beta-d glucan topical composition |
08/09/2000 | EP0642513B1 Indolocarbazole imides and their use |
08/09/2000 | EP0641201B1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
08/09/2000 | CN1262679A IL-5 inhibiting 6-azauracil derivatives |
08/09/2000 | CN1262625A Use of lactoferin in treatment of allergen induced disorders |
08/09/2000 | CN1262624A Use of colchinol derivatives as vascular damaging agents |
08/09/2000 | CN1262616A Topical application of combination of benzoyl peroxide and second active ingredient |
08/09/2000 | CN1262614A Antimicrobial wipes |
08/09/2000 | CN1262611A Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat sebcrrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof |
08/09/2000 | CN1262267A 20 kinds of modified vitamin D series derivatives, preparing and drug thereof |
08/09/2000 | CN1262124A Process for preparing liquid medicine to treat dermatopathy |
08/09/2000 | CN1262113A Chinese-medicinal composition for treating acne |
08/09/2000 | CN1262093A Silver foil cosmetics |
08/09/2000 | CN1055243C Spray preparation for burns and scald and its preparation process |
08/09/2000 | CN1055226C Medicine for curing trichomadesis and its preparation method |
08/09/2000 | CN1055225C Marmot oil ointment for burns and scald |
08/09/2000 | CN1055222C Medical ointment for removing necrotic tissue and promoting tissue regeneration |
08/08/2000 | US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency |
08/08/2000 | US6100282 Thiazole derivatives |
08/08/2000 | US6100266 Hydroxamic and carboxylic acid derivatives |
08/08/2000 | US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents |
08/08/2000 | US6099870 Topical applying agent which inhibits danduff |
08/08/2000 | US6099866 Mixture of beeswax, oil and water |
08/08/2000 | CA2185019C Isoxazoline compounds as inhibitors of tnf release |
08/03/2000 | WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
08/03/2000 | WO2000044863A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof |
08/03/2000 | WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil |
08/03/2000 | WO2000044788A1 Production of tetravalent antibodies |
08/03/2000 | WO2000044763A2 Compositions for treating inflammatory response |
08/03/2000 | WO2000044761A2 Ketolide antibiotics |
08/03/2000 | WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
08/03/2000 | WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases |
08/03/2000 | WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors |
08/03/2000 | WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
08/03/2000 | WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS |
08/03/2000 | WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
08/03/2000 | WO2000044409A1 Formulations comprising antisense nucleotides to connexins |
08/03/2000 | WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens |
08/03/2000 | WO2000044388A1 Modulation of immune response by ribavirin |
08/03/2000 | WO2000044384A1 USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS |
08/03/2000 | WO2000044372A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor |
08/03/2000 | WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
08/03/2000 | WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers |
08/03/2000 | WO2000044342A1 Galenic formulation containing biotin |
08/03/2000 | WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
08/03/2000 | WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists |
08/03/2000 | WO2000015179A3 Cosmetic composition |
08/03/2000 | WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them |
08/03/2000 | WO2000009018A9 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
08/03/2000 | WO2000006589A9 Prostate derived ets factor |
08/03/2000 | WO2000006185A3 Methods of using lanreotide, a somatostatin analogue |
08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods |
08/03/2000 | WO1999062561A3 Gene therapy method |
08/03/2000 | DE19903241A1 Galenische Formulierung Drug formulation |
08/03/2000 | CA2730386A1 Formulations comprising antisense nucleotides to connexins |
08/03/2000 | CA2361614E Compositions for treating inflammatory response |
08/03/2000 | CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors |
08/03/2000 | CA2361246A1 Identification of specific differentially expressed antigens |